The combined HR was 2.11 (95%nCI: 1.59–2.80, P < 0.00001), revealing that OS in cancers was markedly related to SLNCR1 expression, with the high SLNCR1 expression group displaying poorer OS than the low SLNCR1 expression group. Here, LINC00511 is linked to cancer.